FIRM FIXED PRICENO SET ASIDE USED.
TEVA PHARMACEUTICALS USA, INC. - 1 LINE ITEM FOR ALBUTEROL HFA INHALER WITH DOSE COUNTER
PIID: 36E79722D0021Solicitation ID: 36E79722R0008
Signed Date: Jan 9, 2026Effective Date: Jul 28, 2022
Key Details
Description
1 LINE ITEM FOR ALBUTEROL HFA INHALER WITH DOSE COUNTER
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.